Latest News and Press Releases
Want to stay updated on the latest news?
-
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
-
Visiongain has published a new report entitled Alzheimer’s Therapeutics 2022-2032. It includes profiles of Alzheimer’s Therapeutics and Forecasts Market Segment by Drug (Donepezil, Rivastigmine,...
-
Alzheimer’s Drugs Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis
Pune, India, May 05, 2022 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...
-
Visiongain has published a new report on Alzheimer’s Drugs Market Report to 2031: Forecasts by Drugs (Donepezil, Rivastigmine, Galantamine, and Memantine), By Distribution Channel (Hospital...
-
Pune, India, July 14, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global Alzheimer’s drugs market,...
-
Pune, India, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Increasing prevalence of Alzheimer's disease is fueling the demand for Alzheimer’s drugs which in turn is driving the global market, says Fortune...